Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial

Daily contact testing of school-based contacts was non-inferior to self-isolation for control of COVID-19 transmission, with similar rates of symptomatic infections among students and staff with both approaches. Infection rates in school-based contacts were low, with very few school contacts testing positive. Daily contact testing should be considered for implementation as a safe alternative to…

Read the full article here

Source: The Lancet

Categories: General Medicine Journals and Societies, Latest Headlines

Tags: covid19

Tweets with this article

The Lancet

Study of English secondary schools & colleges suggests daily contact testing of school-based contacts should be considered as an alternative to routine isolation—similar rates of symptomatic #COVID19 infections among students & staff with both approaches. https://t.co/cPLFTgIurD https://t.co/wpzZjTTovS

System-level approaches to perinatal depression

During pregnancy or the first year after giving birth, depression affects 1 in 5 individuals worldwide.1,2 In addition to individual suffering and a high risk…

The Lancet April 30, 2024

Effectiveness of two systems-level interventions to address perinatal depression in obstetric settings (PRISM): an active-controlled cluster-randomised trial

Both the MCPAP for Moms and PRISM interventions were equally effective in improving depression symptoms. This finding is important because the 4-point decrease in EPDS…

The Lancet April 30, 2024

Association between maternal mental health-related hospitalisation in the 5 years prior to or during pregnancy and adverse birth outcomes: a population-based retrospective cohort data linkage study in the Northern Territory of Australia

Maternal MHrH is a modifiable risk factor that explained a low to moderate risk of adverse birth outcomes in the Northern Territory. The knowledge highlights…

The Lancet April 30, 2024

Why Latin America needs a regional Centre for Disease Control and Prevention

Home to about 8·2% of the global population, Latin America experienced a disproportionate burden of COVID-19. The region reported 80 million COVID-19 cases and 1·7…

The Lancet April 29, 2024

Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi

In the first 2 years of implementation of RTS,S, the three primary doses were effectively deployed through national immunisation programmes. There was no evidence of…

The Lancet April 29, 2024

10 years on: the legacy of the Flint water crisis

The exposure of residents to lead in drinking water caused a national outcry, prompting requirements to update infrastructure and tighten water quality standards. Susan Jaffe…

The Lancet April 28, 2024

Aid groups call for help for migrants in Belarus

Civil society has been limited by President Alexander Lukashenko, leaving few organisations to provide health care for migrants at the Belarus–EU border. Ed Holt reports.

The Lancet April 28, 2024

Air pollution exposure and cardiometabolic risk

The Global Burden of Disease assessment estimates that 20% of global type 2 diabetes cases are related to chronic exposure to particulate matter (PM) with…

The Lancet April 27, 2024

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

In this prespecified pooled analysis of the STEP-HFpEF and STEP-HFpEF DM trials, semaglutide was superior to placebo in improving heart failure-related symptoms and physical limitations,…

The Lancet April 27, 2024

Moderna stalls on African vaccine manufacturing plans

Moderna’s decision has been criticised by the Africa CDC, with experts urging countries to invest domestically. Paul Adepoju reports.

The Lancet April 27, 2024

Related Articles